The World Health Organization (WHO) has released new estimates that project a significant surge in global cancer cases by 2050. According to the report, there will be an alarming 77% increase in cancer diagnoses, soaring from 20 million cases in 2022 to a staggering 35 million cases in 2050. The findings, based on data from 185 countries and encompassing 36 different types of cancer, shed light on the growing burden of this disease worldwide.
In 2022, lung cancer emerged as the most prevalent form of cancer globally, accounting for 2.5 million cases, or 12.4% of the total. It was followed by breast, colorectal, prostate, and stomach cancers. Lung cancer also claimed the highest number of lives with 1.8 million deaths, representing nearly 19% of all cancer-related mortalities.
The WHO report highlights the disparities in cancer burden across different nations. Countries with a high Human Development Index (HDI), which measures factors like health, education, and standard of living, exhibit significant discrepancies in breast cancer rates. In these countries, 1 in 12 women are diagnosed with breast cancer, and 1 in 71 will succumb to it. Conversely, in low-HDI countries, breast cancer diagnosis rates are lower at 1 in 27, but the mortality rate is higher at 1 in 48. This discrepancy can mainly be attributed to delayed diagnoses and limited access to adequate treatments.
Furthermore, inequities in cancer services, such as radiation and stem cell transplants, were also observed across countries. These disparities underscore the urgent need for increased investments and policy initiatives to address global inequalities in cancer outcomes.
The study identifies various factors contributing to the projected rise in cancer rates. Lifestyle choices like obesity, tobacco use, and alcohol consumption play a significant role, as well as environmental factors such as air pollution.
While the United States has witnessed a decline in cancer-related deaths due to reduced tobacco usage, early detection, and improved treatments, certain forms of cancer are on the rise among specific demographics. A recent report by the American Cancer Society indicates that colorectal cancer diagnoses among adults under 55 have increased from 11% in 1995 to 20% in 2019. Racial disparities in cancer outcomes persist, highlighting the need for targeted interventions.
Addressing the global cancer crisis has become a priority for President Joe Biden's administration. The Cancer Moonshot effort, aimed at reducing US cancer deaths by half within 25 years, involves collaboration between agencies like NASA, the Environmental Protection Agency, and the Department of Health and Human Services. However, the fight against cancer requires not only resources but also political will to ensure equitable access to affordable and quality cancer care.
Dr. Cary Adams, head of the Union for International Cancer Control, emphasizes that despite the progress made in cancer treatment, disparities still exist both between and within countries. It is crucial for governments to prioritize cancer care and ensure that everyone has access to the necessary services. Ultimately, the goal should be to eliminate the notion that where a person lives determines their chances of survival.